Ritha A. Njau

Dar Es Salaam, United Republic of Tanzania

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 23 publications

Temporal trends in artemisinin partial resistance and other antimalarial drug mutations in Plasmodium falciparum from Kagera region, Northwestern Tanzania, 2021-2023.

Temporal trends in artemisinin partial resistance and other antimalarial drug mutations in Plasmodium falciparum from Kagera region, Northwestern Tanzania, 2021-2023.

Journal: Frontiers in genetics

Published: December 26, 2025

Temporal Trends in Artemisinin Partial Resistance and Other Antimalarial Drug Mutations in Plasmodium falciparum from Kagera Region, Northwestern Tanzania, 2021-2023.

Temporal Trends in Artemisinin Partial Resistance and Other Antimalarial Drug Mutations in Plasmodium falciparum from Kagera Region, Northwestern Tanzania, 2021-2023.

Journal: medRxiv : the preprint server for health sciences

Published: December 08, 2025

Evidence of artemisinin partial resistance in North-western Tanzania: clinical and drug resistance markers study.

Evidence of artemisinin partial resistance in North-western Tanzania: clinical and drug resistance markers study.

Journal: medRxiv : the preprint server for health sciences

Published: February 14, 2024

Evidence of artemisinin partial resistance in northwestern Tanzania: clinical and molecular markers of resistance.

Evidence of artemisinin partial resistance in northwestern Tanzania: clinical and molecular markers of resistance.

Journal: The Lancet. Infectious diseases

Published: February 13, 2024

Trends of Plasmodium falciparum molecular markers associated with resistance to artemisinins and reduced susceptibility to lumefantrine in Mainland Tanzania from 2016 to 2021.

Trends of Plasmodium falciparum molecular markers associated with resistance to artemisinins and reduced susceptibility to lumefantrine in Mainland Tanzania from 2016 to 2021.

Journal: Malaria journal

Published: January 18, 2024

Prevalence of mutations associated with artemisinin partial resistance and sulfadoxine-pyrimethamine resistance in 13 regions in Tanzania in 2021: a cross-sectional survey.

Prevalence of mutations associated with artemisinin partial resistance and sulfadoxine-pyrimethamine resistance in 13 regions in Tanzania in 2021: a cross-sectional survey.

Journal: The Lancet. Microbe

Published: December 15, 2023

Microsatellites reveal high polymorphism and high potential for use in anti-malarial efficacy studies in areas with different transmission intensities in mainland Tanzania.

Microsatellites reveal high polymorphism and high potential for use in anti-malarial efficacy studies in areas with different transmission intensities in mainland Tanzania.

Journal: Malaria journal

Published: December 09, 2023

Country wide surveillance reveals prevalent artemisinin partial resistance mutations with evidence for multiple origins and expansion of high level sulfadoxine-pyrimethamine resistance mutations in northwest Tanzania.

Country wide surveillance reveals prevalent artemisinin partial resistance mutations with evidence for multiple origins and expansion of high level sulfadoxine-pyrimethamine resistance mutations in northwest Tanzania.

Journal: medRxiv : the preprint server for health sciences

Published: November 21, 2023

Efficacy and safety of artemether-lumefantrine for the treatment of uncomplicated falciparum malaria in mainland Tanzania, 2018.

Efficacy and safety of artemether-lumefantrine for the treatment of uncomplicated falciparum malaria in mainland Tanzania, 2018.

Journal: Malaria journal

Published: October 31, 2023

Plasmodium falciparum pfhrp2 and pfhrp3 gene deletions among patients enrolled at 100 health facilities throughout Tanzania: February to July 2021.

Plasmodium falciparum pfhrp2 and pfhrp3 gene deletions among patients enrolled at 100 health facilities throughout Tanzania: February to July 2021.

Journal: Scientific reports

Published: October 26, 2023

Impact of 1,7-malaria reactive community-based testing and response (1,7-mRCTR) approach on malaria prevalence in Tanzania.

Impact of 1,7-malaria reactive community-based testing and response (1,7-mRCTR) approach on malaria prevalence in Tanzania.

Journal: Infectious diseases of poverty

Published: September 11, 2023

Efficacy of artesunate-amodiaquine for treatment of uncomplicated Plasmodium falciparum malaria in mainland Tanzania.

Efficacy of artesunate-amodiaquine for treatment of uncomplicated Plasmodium falciparum malaria in mainland Tanzania.

Journal: Malaria journal

Published: August 29, 2023

Showing 1-12 of 23

Last Updated: 09/26/2026